Table 1 Clinical and demographic characteristics of the study groups.
From: Oxidative stress in hepatitis C infected end-stage renal disease subjects
Study Groups | HCV (+) HD subjects | HCV (-) HD subjects | Control subjects |
|---|---|---|---|
N | 16 | 24 | 24 |
Age (year) | 50.3 ± 10 | 46.8 ± 8.5 | 40.4 ± 7.3 |
Gender (M/F) | 10/6 | 13/11 | 14/10 |
Uric Acid (mg/dL) | 5.5 ± 1.5* | 5.54 ± 1.25* | 4.4 ± 0.3 |
BUN (mg/dL) | 61 ± 23* | 65 ± 31* | 16 ± 5.5 |
ALT | 27 ± 13.7 | 22.4 ± 10.7 | 23.3 ± 4.8 |
Creatinine (mg/dL) | 6.05 ± 2.4* | 7.01 ± 1.5* | 0.97 ± 0.15 |
HCV-RNA (log copies/mL) | 4.9 ± 0.7 | -- | -- |
DD (Years) | 4.25 ± 2.5 | 3.35 ± 2.7 | -- |
TAC ( mmol Trolox eq./L) | 1.27 ± 0.2 | 1.68 ± 0.4 | 2.1 ± 0.6** |
TP (micromole H2O2/L) | 12.9 ± 6.1** | 10.9 ± 6.9** | 5.2 ± 2.1 |
OSI (%) | 1.6 ± 0.6** | 1.1 ± 0.9** | 0.3 ± 0.1 |